Amgen sales rise 4% in first quarter, submits label update to FDA on autoimmune drug

Amgen on Thursday reported first-quarter product sales rose 4%, helped by demand for cholesterol and rare disease medicines, and ​said it was moving forward with a broad development program ‌for experimental weight-loss drug MariTide.